Dermatologic Events From EGFR Inhibitors: The Issue of the Missing Patient Voice

Supportive Care in Cancer - Germany
doi 10.1007/s00520-016-3419-4
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Management of Egfr Tki–induced Dermatologic Adverse Events

Current Oncology
Oncology
2015English

A Systematic Review of Patient-Reported Outcome Instruments of Dermatologic Adverse Events Associated With Targeted Cancer Therapies

Supportive Care in Cancer
Oncology
2015English

Management of Immune Checkpoint Inhibitor‐related Dermatologic Adverse Events

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

On the Missing Energy Puzzle of Tidal Disruption Events

Astrophysical Journal
AstrophysicsAstronomyPlanetary ScienceSpace
2018English

Towards Meaningful Engagement for the Patient Voice

Patient
Nursing
2019English

Incorporating the Patient Voice Into Practice Improvement:

Family Medicine
Family Practice
2019English

Book on AIDS Missing From Special Issue

American Journal of Occupational Therapy
MedicineOccupational Therapy
1990English

Integration of EGFR Inhibitors With Radiochemotherapy

Nature Reviews Cancer
Cancer ResearchOncology
2006English

1079 Phospho-Proteomic Profiling Reveals Distinct Signaling Pathways by First and Third Generation EGFR Inhibitors in Human Keratinocytes: Implications for Adverse Dermatologic Reactions

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy